Patents by Inventor Olaf Weber

Olaf Weber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240391749
    Abstract: A system for treating kegs with data carriers. One or more treatment modules, each of which has a keg receiving area, a treatment head, and an one interface for a discharge line and for a cleaning medium line and/or at least one filling product line. A signaling device configured for signaling operations to be carried out with the treatment modules and/or a loading device for supplying and discharging the kegs to and from the treatment modules. A controller configured for controlling the treatment modules, the signaling device, and/or the feed device. A reading device connected to the controller for reading information from the data carriers. The controller being configured to control and/or regulate the treatment of the kegs, in particular a cleaning process and/or a filling process, in the treatment modules based on the information on the data carriers. The information being read by the reading device.
    Type: Application
    Filed: August 30, 2022
    Publication date: November 28, 2024
    Inventors: Volker Damerow, Sebastian Eckes, Maximilian Weindorf, Christian Pedersen, Manfred Wahl, Andreas Weber, Olaf Muszinski
  • Publication number: 20240383739
    Abstract: A system for treating kegs with at least two treatment modules. Each treatment module has a keg receiving area, a treatment head, and an interface. The system contains a controller for controlling the treatment modules. At least one of the treatment modules is connected to a filling product source, which provides a first filling product, via the respective interface of the treatment module. At least one other treatment module of the treatment modules is connected to a filling product source, which provides a second filling product, via the respective interface of the treatment module. The controller is designed to actuate the treatment modules for a simultaneous and/or a delayed filling process for different filling products.
    Type: Application
    Filed: August 30, 2022
    Publication date: November 21, 2024
    Inventors: Volker Damerow, Sebastian Eckes, Maximilian Weindorf, Christian Pedersen, Manfred Wahl, Andreas Weber, Olaf Muszinski
  • Publication number: 20240351843
    Abstract: The invention relates to a treatment system for treating containers, in particular for treating kegs, each of which is preferably equipped with at least one keg fitting. The treatment system has at least one media supply for a product to be filled and/or for one or more treatment or cleaning media as well as at least one treatment station for receiving a container, in particular keg. The treatment station has at least one treatment head for cleaning the interior of and/or filling the container, in particular keg, and at least one supply interface via which the treatment station is connected to the media supply. According to the invention, at least one closure device for tightly closing the treatment head as well as at least one measuring and checking device for recording and checking process data are further provided in the treatment system for automatically checking installation and/or functioning of the treatment station.
    Type: Application
    Filed: August 30, 2022
    Publication date: October 24, 2024
    Inventors: Volker Damerow, Sebastian Eckes, Maximilian Weindorf, Christian Pedersen, Manfred Wahl, Andreas Weber, Olaf Muszinski
  • Patent number: 10898500
    Abstract: The present invention relates to pharmaceutical compositions and combinations comprising regorafenib and acetylsalicylic acid, or a hydrate, solvate, metabolite or pharmaceutically acceptable salt thereof or a polymorph thereof for treating, preventing or managing diseases and conditions including hyperproliverative disorders such as cancer in humans and other mammals.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: January 26, 2021
    Assignees: BAYER PHARMA AKTIENGESELLSCHAFT, BAYER AG
    Inventors: Olaf Weber, Karl Ziegelbauer
  • Publication number: 20190292231
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Application
    Filed: June 12, 2019
    Publication date: September 26, 2019
    Applicant: AiCuris GmbH & Co. KG
    Inventors: Olaf WEBER, Sonja Maria TENNAGELS, Angela SIEGLING, Tobias SCHLAPP, Andrew Allan MERCER, Stephen Bruce FLEMING, Hans-Dieter VOLK
  • Publication number: 20170320918
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Application
    Filed: July 20, 2017
    Publication date: November 9, 2017
    Applicant: AiCuris GmbH & Co. KG
    Inventors: Olaf WEBER, Sonja Maria TENNAGELS, Angela SIEGLING, Tobias SCHLAPP, Andrew Allan MERCER, Stephen Bruce FLEMING, Hans-Dieter VOLK
  • Patent number: 9714272
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: July 25, 2017
    Assignee: AICURIS GMBH & CO. KG
    Inventors: Olaf Weber, Sonja Maria Tennagels, Angela Siegling, Tobias Schlapp, Andrew Allan Mercer, Stephen Bruce Fleming, Hans-Dieter Volk
  • Publication number: 20150202214
    Abstract: The present invention relates to pharmaceutical compositions and combinations comprising regorafenib and acetylsalicylic acid, or a hydrate, solvate, metabolite or pharmaceutically acceptable salt thereof or a polymorph thereof for treating, preventing or managing diseases and conditions including hyperproliverative disorders such as cancer in humans and other mammals.
    Type: Application
    Filed: September 23, 2013
    Publication date: July 23, 2015
    Applicants: BAYER PHARMA AKTIENGESELLSCHAFT, BAYER AG
    Inventors: Olaf Weber, Karl Ziegelbauer
  • Publication number: 20140377297
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Application
    Filed: September 8, 2014
    Publication date: December 25, 2014
    Inventors: Olaf WEBER, Sonja Maria TENNAGELS, Angela SIEGLING, Tobias SCHLAPP, Andrew Allan MERCER, Stephen Bruce FLEMING, Hans-Dieter VOLK
  • Patent number: 8852577
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: October 7, 2014
    Assignee: AiCuris GmbH & Co. KG
    Inventors: Olaf Weber, Sonja Maria Tennagels, Angela Siegling, Tobias Schlapp, Andrew Allan Mercer, Stephen Bruce Fleming, Hans-Dieter Volk
  • Publication number: 20140283588
    Abstract: A method of diagnosing a cooling subsystem of an engine system in response a parameter extracted from dynamic hydraulic pressure sensed in the cooling subsystem, and products and systems using same.
    Type: Application
    Filed: June 9, 2014
    Publication date: September 25, 2014
    Inventors: Olaf Weber, Wolfgang Wenzel
  • Patent number: 8751101
    Abstract: A method of diagnosing a cooling subsystem of an engine system in response a parameter extracted from dynamic hydraulic pressure sensed in the cooling subsystem, and products and systems using same.
    Type: Grant
    Filed: July 7, 2009
    Date of Patent: June 10, 2014
    Assignee: BorgWarner Inc.
    Inventors: Olaf Weber, Wolfgang Wenzel
  • Patent number: 8529675
    Abstract: An air filter system with an air filter element having an inflow and an outflow face and comprising alternating flat and pleated layers, which are configured to form channels. The channels are alternately sealed in inflow and outflow direction, such that the medium to be filtered must pass through one of the layers as it flows from the inflow face through the filter to the outflow face. An adsorber element made of an activated carbon coated honeycomb structure is disposed adjacent the air filter element.
    Type: Grant
    Filed: November 17, 2005
    Date of Patent: September 10, 2013
    Assignee: Mann+Hummel GmbH
    Inventors: Michael Durst, Nikolaus Moser, Andreas Pelz, Olaf Weber
  • Patent number: 8357363
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: January 22, 2013
    Assignee: Aicuris GmbH & Co. KG
    Inventors: Olaf Weber, Sonja Maria Friederichs, Angela Siegling, Tobias Schlapp, Andrew Allan Mercer, Stephen Bruce Fleming, Hans-Dieter Volk
  • Patent number: 8343478
    Abstract: The present invention relates to the use of Parapoxviruses in combination with other agents for the treatment of viral diseases, and in particular HIV infections and AIDS. The invention also relates to methods for producing medicaments based on combinations of Parapoxviruses and other antiviral agents, and to such medicaments. In particular, the invention relates to the use of Parapoxviruses in combination with agents of the kind used for antiretroviral therapy and highly active antiretroviral therapy (HAART).
    Type: Grant
    Filed: January 11, 2007
    Date of Patent: January 1, 2013
    Assignee: AiCuris GmbH & Co. KG
    Inventors: Daniela Paulsen, Helga Ruebsamen-Schaeff, Amar Kureishi, Gerhard Hunsmann, Christiane Stahl-Hennig, Andreas Meyerhans, Alexandra Schuetz, Olaf Weber
  • Publication number: 20120330575
    Abstract: A method includes sensing pressure within an engine cylinder, and estimating at least one other engine system parameter based on the sensed pressure. Another method includes designing an engine system, which includes one or more engine cylinder pressure sensors and one or more other engine system sensors. According to this method, the engine system is operated, and engine cylinder pressure is sensed using the engine cylinder pressure sensors, which are in communication with an engine cylinder of an engine of the engine system. Also, other engine system parameters are sensed to obtain at least one other engine system parameter using the other engine system sensors. The engine cylinder pressure is correlated to the at least one other engine system parameter, and engine cylinder pressure is used to replace or augment the at least one other engine system parameter that correlates to the engine cylinder pressure.
    Type: Application
    Filed: October 5, 2007
    Publication date: December 27, 2012
    Applicant: BORGWARNER INC.
    Inventors: Olaf Weber, John Shutty, Wolfgang Wenzel
  • Patent number: 8227511
    Abstract: The present invention relates to substituted chromanol derivatives, to processes for their preparation, to their use on their own or in combination for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: July 24, 2012
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Carsten Schmeck, Hilmar Bischoff, Volkhart Li, Klemens Lustig, Michael Thutewohl, Alexandros Vakalopoulos, Olaf Weber
  • Publication number: 20120142728
    Abstract: The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis.
    Type: Application
    Filed: February 16, 2012
    Publication date: June 7, 2012
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Hilmar BISCHOFF, Heike GIELEN-HAERTWIG, Volkhart LI, Carsten SCHMECK, Michael THUTEWOHL, Alexandros VAKALOPOULOS, Olaf WEBER, Martina WUTTKE
  • Patent number: 8171731
    Abstract: An air management assembly (10) for use in an engine (12) with an exhaust manifold (14) that outputs an exhaust gas and an intake manifold (16), with a filter (18) in fluid communication between the exhaust manifold (14) and turbocharger (20). The air management assembly (10) provides a compressor (22), a turbine (24), at least one gaseous fluid cooler (32, 36, 44), at least one bypass (28, 28)? and a housing (30) where the compressor (22), turbine (24), at least one gaseous fluid cooler (32), (36, 44), bypass (28, 28?), or combination thereof are integrated into the housing (30). The compressor (22) is in fluid communication with the intake manifold (16). The turbine (24) is in fluid communication with the exhaust manifold (14). The turbine (24) and the compressor (22) are moveably coupled and move in conjunction with one another. The gaseous fluid coolers (32, 36, 44) are in fluid communication with the compressor (32), turbine (24), or combination thereof.
    Type: Grant
    Filed: May 11, 2006
    Date of Patent: May 8, 2012
    Assignee: BorgWarner Inc.
    Inventors: Volker Joergl, Timm Kiener, Olaf Weber
  • Patent number: 8124775
    Abstract: The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: February 28, 2012
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Hilmar Bischoff, Heike Gielen-Haertwig, Volkhart Li, Carsten Schmeck, Michael Thutewohl, Alexandros Vakalopoulos, Olaf Weber, Martina Wuttke